Akshay S Thomas1, Travis Redd2, John P Campbell2, Neal V Palejwala3, Justin T Baynham4, Eric B Suhler2,5, James T Rosenbaum2,6, Phoebe Lin2. 1. a Department of Ophthalmology , Duke University Eye Center , Durham , North Carolina , USA. 2. b Department of Ophthalmology, Casey Eye Institute , Oregon Health and Science University , Portland , Oregon , USA. 3. c Retina Consultants of Arizona , Phoenix , Arizona , USA. 4. d Retina Consultants, LLC , Salem , Oregon , USA. 5. e Portland Veteran's Affairs Medical Center , Portland , Oregon , USA. 6. f Devers Eye Institute , Portland , Oregon , USA.
Abstract
Purpose: To study if peripheral vascular leakage (PVL) on ultra-widefield fluorescein angiography (UWFFA) prognosticates complications of uveitis or necessitates treatment augmentation. Methods: Retrospective cohort study of uveitis patients imaged with UWFFA and ≥1 yr of follow-up. Results: We included 73 eyes of 42 patients with uveitis. There was no difference in baseline, intermediate, final visual acuity (p = 0.47-0.95) or rates of cystoid macular edema (CME) (p = 0.37-0.87) in eyes with PVL vs. those without. Eyes with PVL receiving baseline treatment augmentation were more likely to have baseline CME but were not more likely to have impaired visual acuity at final follow-up. PVL was independently associated with treatment augmentation on generalized estimating equation analysis with multivariable linear regression (OR: 4.39, p = 0.015). Conclusions: PVL did not confer an increased risk of impaired VA or CME at ≥1 yr follow-up but was possibly an independent driver of treatment augmentation.
Purpose: To study if peripheral vascular leakage (PVL) on ultra-widefield fluorescein angiography (UWFFA) prognosticates complications of uveitis or necessitates treatment augmentation. Methods: Retrospective cohort study of uveitispatients imaged with UWFFA and ≥1 yr of follow-up. Results: We included 73 eyes of 42 patients with uveitis. There was no difference in baseline, intermediate, final visual acuity (p = 0.47-0.95) or rates of cystoid macular edema (CME) (p = 0.37-0.87) in eyes with PVL vs. those without. Eyes with PVL receiving baseline treatment augmentation were more likely to have baseline CME but were not more likely to have impaired visual acuity at final follow-up. PVL was independently associated with treatment augmentation on generalized estimating equation analysis with multivariable linear regression (OR: 4.39, p = 0.015). Conclusions: PVL did not confer an increased risk of impaired VA or CME at ≥1 yr follow-up but was possibly an independent driver of treatment augmentation.
Authors: Ayyakkannu Manivannan; Jarka Plskova; Alison Farrow; Sandra Mckay; Peter F Sharp; John V Forrester Journal: Am J Ophthalmol Date: 2005-09 Impact factor: 5.258
Authors: John Peter Campbell; Henry Alexander Leder; Yasir Jamal Sepah; Theresa Gan; James P Dunn; Elham Hatef; Brian Cho; Mohamed Ibrahim; Millena Bittencourt; Roomasa Channa; Diana V Do; Quan Dong Nguyen Journal: Am J Ophthalmol Date: 2012-08-28 Impact factor: 5.258
Authors: Matthew M Wessel; Grant D Aaker; George Parlitsis; Minhee Cho; Donald J D'Amico; Szilárd Kiss Journal: Retina Date: 2012-04 Impact factor: 4.256
Authors: Pradeep S Prasad; Scott C N Oliver; Robert E Coffee; Jean-Pierre Hubschman; Steven D Schwartz Journal: Ophthalmology Date: 2010-01-04 Impact factor: 12.079
Authors: Matthew M Wessel; Nandini Nair; Grant D Aaker; Joshua R Ehrlich; Donald J D'Amico; Szilárd Kiss Journal: Br J Ophthalmol Date: 2012-03-15 Impact factor: 4.638
Authors: Henry A Leder; John P Campbell; Yasir J Sepah; Theresa Gan; James P Dunn; Elham Hatef; Brian Cho; Mohamed Ibrahim; Millena Bittencourt; Roomasa Channa; Diana V Do; Quan Dong Nguyen Journal: J Ophthalmic Inflamm Infect Date: 2013-02-11